5 trends to watch at the FDA in 2020
With new Commissioner Stephen Hahn at the lead, the FDA faces several important pressures as it kicks off the year. From not erecting too many barriers to drug approval to implementing drug importation initiatives, some question how this will affect the agency’s ability to deliver only quality therapies to market. Here are five key trends to watch at the FDA in 2020s:
- Faster Approvals
- Advanced Therapies
- Drug Prices
- Right to Try
- New Leadership
